A [5, 6-3H]-niacin CEP of the European Pharmacopoeia monograph is often referred to as a [5, 6-3H]-niacin Certificate of Suitability (COS). The purpose of a [5, 6-3H]-niacin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of [5, 6-3H]-niacin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of [5, 6-3H]-niacin to their clients by showing that a [5, 6-3H]-niacin CEP has been issued for it. The manufacturer submits a [5, 6-3H]-niacin CEP (COS) as part of the market authorization procedure, and it takes on the role of a [5, 6-3H]-niacin CEP holder for the record. Additionally, the data presented in the [5, 6-3H]-niacin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the [5, 6-3H]-niacin DMF.
A [5, 6-3H]-niacin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. [5, 6-3H]-niacin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of [5, 6-3H]-niacin suppliers with CEP (COS) on PharmaCompass.